Stocks
Eli Lilly and Company (LLY) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 8 043 | 8 661 | 8 568 | 15 228 | 27 937 | 33 133 | ||
| Changes by years, y/y, % | -10% | +8% | -1% | +78% | +83% | +25.7% | |||
Eli Lilly and Company. EBITDA US GAAP, bln rub
Eli Lilly and Company. EBITDA US GAAP, changes, %
Eli Lilly and Company. EBITDA US GAAP, sum by quarters, bln rub
Eli Lilly and Company (LLY) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 4 163 | 7 504 | 7 882 | 8 388 | 9 359 | 33 133 | |
| Changes by years, y/y, % | +34% | +82% | +251% | +46% | +125% | |||
| Changes by quarters, q/q, % | -28% | +80% | +5% | +6% | +12% | |||
